Literature DB >> 10891334

Heme degradation during autoxidation of oxyhemoglobin.

E Nagababu1, J M Rifkind.   

Abstract

Two fluorescent heme degradation compounds are detected during autoxidation of oxyhemoglobin. These fluorescent compounds are similar to fluorescent compounds formed when hydrogen peroxide reacts with hemoglobin [E. Nagababu and J. M. Rifkind, Biochem. Biophys. Res. Commun. 247, 592-596 (1998)]. Low levels of heme degradation in the presence of superoxide and catalase are attributed to a reaction involving the superoxide produced during autoxidation. The inhibition of most of the degradation by catalase suggests that the hydrogen peroxide generated during autoxidation of oxyhemoglobin produces heme degradation by the same mechanism as the direct addition of hydrogen peroxide to hemoglobin. The formation of the fluorescent degradation products was inhibited by the peroxidase substrate, ABTS, which reduces ferrylhemoglobin to methemoglobin, indicating that ferrylhemoglobin is produced during the autoxidation of hemoglobin. It is the transient formation of this highly reactive Fe(IV) hemoglobin, which is responsible for most of the heme degradation during autoxidation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891334     DOI: 10.1006/bbrc.2000.3025

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Hemoglobin redox reactions and red blood cell aging.

Authors:  Joseph M Rifkind; Enika Nagababu
Journal:  Antioxid Redox Signal       Date:  2012-11-09       Impact factor: 8.401

2.  Antichaperone activity and heme degradation effect of methyl tert-butyl ether (MTBE) on normal and diabetic hemoglobins.

Authors:  Ismaeil Hossein Najdegerami; Parvaneh Maghami; Vahid Sheikh-Hasani; Ghader Hosseinzadeh; Nader Sheibani; Ali A Moosavi-Movahedi
Journal:  J Mol Recognit       Date:  2016-12-05       Impact factor: 2.137

3.  Oxidative stress in erythrocytes: a study on the effect of antioxidant mixtures during intermittent exposures to high altitude.

Authors:  R Vani; C S Shiva Shankar Reddy; S Asha Devi
Journal:  Int J Biometeorol       Date:  2010-02-19       Impact factor: 3.787

4.  A heme•DNAzyme activated by hydrogen peroxide catalytically oxidizes thioethers by direct oxygen atom transfer rather than by a Compound I-like intermediate.

Authors:  Nisreen M Shumayrikh; Jeffrey J Warren; Andrew J Bennet; Dipankar Sen
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

5.  Role of the membrane in the formation of heme degradation products in red blood cells.

Authors:  Enika Nagababu; Joy G Mohanty; Surya Bhamidipaty; Graciela R Ostera; Joseph M Rifkind
Journal:  Life Sci       Date:  2009-12-01       Impact factor: 5.037

6.  Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.

Authors:  Kevin J Woollard; Sharelle Sturgeon; Jaye P F Chin-Dusting; Hatem H Salem; Shaun P Jackson
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

7.  Red blood cells induce hypoxic lung inflammation.

Authors:  Rainer Kiefmann; Joseph M Rifkind; Enika Nagababu; Jahar Bhattacharya
Journal:  Blood       Date:  2008-02-12       Impact factor: 22.113

8.  Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.

Authors:  E Nagababu; J G Mohanty; J S Friedman; J M Rifkind
Journal:  Free Radic Res       Date:  2013-01-09

9.  Heme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C disease.

Authors:  Enika Nagababu; Mary E Fabry; Ronald L Nagel; Joseph M Rifkind
Journal:  Blood Cells Mol Dis       Date:  2008-02-08       Impact factor: 3.039

10.  Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases.

Authors:  Rasmus Larsen; Zélia Gouveia; Miguel P Soares; Raffaella Gozzelino
Journal:  Front Pharmacol       Date:  2012-05-04       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.